CNN's Ana Cabrera speaks with Dr. Joel Perlmutter about his decision to resign from an FDA panel over the agency's approval of the controversial drug aducanumab to treat Alzheimer's.

TownNews.com Content Exchange

Tags

TownNews.com Content Exchange